Skip to main content
. 2022 Aug 30;9(9):427. doi: 10.3390/bioengineering9090427

Figure 6.

Figure 6

Antibacterial activity results of the scaffolds against the S. aureus (a) and E. coli (b); IB (25% PCL/1.25 J), IIB (25% PCL/2.5 J), IIIB (25% PCL/5 J), IVB (25% PCL/7.5 J), VB (25% PCL/10 J), and KB (25% PCL).